Engineering Protease-Resistant Peptides for Better Drug Targeting and Delivery | Research

The takeaway

Review of chemical strategies to make peptides resistant to enzymatic degradation while maintaining their targeting and intracellular delivery capabilities for next-generation therapeutics.

Stability toolkit
Multiple chemical strategies — D-amino acids, cyclization, PEGylation, backbone modifications — each address peptide instability with different trade-offs for drug development

What the researchers found

Comprehensive review of strategies to enhance peptide proteolytic resistance for targeting and intracellular delivery: D-amino acids, cyclization, PEGylation, unnatural amino acids, backbone modifications, and hybrid approaches.

Why it matters

Proteolytic degradation is the single biggest barrier to peptide therapeutics. A comprehensive understanding of stabilization strategies enables rational design of peptide drugs that survive in the body.

The numbers in context

Strategies: N/C-cap, cyclization, backbone mod, D-amino acids, conjugation; best for brain delivery: retro-enantio

How the study worked

Narrative review of chemical modification strategies for protease-resistant peptide design in drug delivery applications.

Who was studied

N/A (review of peptide chemistry and delivery literature)

What this study cannot tell us

Review article. Different strategies suit different peptide applications. Some modifications may reduce biological activity. Manufacturing complexity varies widely.

How to read the evidence

Not applicable (review article).

When this study was published

Published 2021.

The bigger picture

As peptide drugs grow from niche to mainstream therapeutics, protease resistance engineering becomes a standard pharmaceutical discipline. This review provides the design toolkit.

Questions still open

Which stabilization strategy best preserves cell-penetrating activity?
Can AI predict optimal combinations of modifications for specific peptide drugs?
What are the cost implications of each approach for pharmaceutical manufacturing?

Common questions

Why do peptide drugs break down so fast?

The body contains thousands of proteases — enzymes whose job is to break down proteins and peptides. Therapeutic peptides are seen as food by these enzymes. Chemical modifications can disguise or protect peptides from this degradation.

Which modification works best?

It depends on the peptide and application. Cyclization works well for oral delivery, D-amino acids for enzyme resistance, PEGylation for extending half-life. Often, combining multiple strategies provides the best result.

Read the original research

Protease-Resistant Peptides for Targeting and Intracellular Delivery of Therapeutics.

Pharmaceutics, 13(12)

View on PubMed ↗Publisher’s paper ↗

Citation

Lucana, Maria C; Arruga, Yolanda; Petrachi, Emilia; Roig, Albert; Lucchi, Roberta; Oller-Salvia, Benjamí. (2021). Protease-Resistant Peptides for Targeting and Intracellular Delivery of Therapeutics.. Pharmaceutics, 13(12). https://doi.org/10.3390/pharmaceutics13122065